A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Clinical trial NCT05037760 · RECRUITING
Trial details
- NCT number
- NCT05037760
- Sponsor
- Takeda
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2028-02-28
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.